1. Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K,
Chinegwundoh F, Corbishley C, Dorling D, Thomas B, Gillatt D, Kirby
R, Muir G, Nargund V, Popert R, Metcalfe C, Persad R; PROCESS study
group.The Risk of Prostate Cancer amongst Black men in the United
Kingdom: The PROCESS Cohort Study, European Urology 53 (2008)
2. Roehrborn CG. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE. BJU International. 2008; 101 (supp 3): 17-21.
3. Popiolek M, et al. Natural History of Early, Localized Prostate Cancer: A Final Report from Three Decades of Follow-up. Eur Urol (2012),
4. From the CRUK statistical information team, compiled from: Northern Ireland Cancer Registry. Cancer Incidence and Mortality. 2010; Welsh Cancer Intelligence and Surveillance Unit.2010, ISD Online Information and Statistics Division, NHS Scotland. 2010; Office for National Statistics, Cancer Statistics registrations: Registrations of cancer diagnosed in 2007, England Series MB1 no.38. 2010, London: National Statistics
5. Xu J, Kibel AS, Hu JJ, Turner AR, Pruett K, Zheng SL, Sun J, Isaacs SD, Wiley KE, Kim ST, Hsu FC, Wu W, Torti FM, Walsh PC, Chang BL, Isaacs WB.Prostate cancer risk associated loci in African Americans Cancer Epidemiol Markers Prev 2009; 18(7) 2145-49).
6. Hooker S, Hernandez W, Chen H, Robbins C, Torres JB, Ahaghotu C, Carpten J, Kittles RA.Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans Prostate 2010 Feb 15;70(3):270-6).
7. Wang Y, Ray AM, Johnson EK, Zuhlke KA, Cooney KA, Lange EM. Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: The flint men's health study† Prostate 2010 Aug 17).
8. Lavender NA, Benford ML, VanCleave TT, Brock GN, Kittles RA, Moore JH, Hein DW, Kidd LC.Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among Men of African Descent: A case-control study BMC Cancer 2009 9: 397)
9. Mason TE, Ricks-Santi L, Chen W, Apprey V, Joykutty J, Ahaghotu C, Kittles R, Bonney G, Dunston GM.Association of CD14 variant with prostate cancer in African American men Prostate 2010 Feb 15;70(3):262-9)
10. Kheirandish, P and Chinegwundoh, F. Ethnic differences in prostate cancer. British Journal of Cancer 2011; 105, 481-485.
11. Rebbeck, TR, Devesa, S.S and Chang, BL et al. Global patterns of prostate cancer incidence, aggressiveness and mortality in men of African Descent. Prostate Cancer. 2013
12. Bandolier Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU International 2003; 91: 789-794.
13. Giovannucci E, Liu Y, Platz EA et al. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int.J Cancer 2007; 121 (7):1571-8
14. Orsini N, Bellocco R, Bottai M, Pagano M, Andersson SO, Johansson JE, Giovannucci E, Wolk A. A prospective study of lifetime physical activity and prostate cancer incidence and mortality Br J Cancer. 2009 Dec 1;101(11):1932-8. Epub 2009 Oct 27.
15. World Cancer Research Fund/American Institute for Cancer. Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. Washington DC:AICR, 2007
16. Ma RW, Chapman K .A systematic review of the effect of diet in prostate cancer prevention and treatment. Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association [2009, 22(3):187-99; quiz 200-2]
17. Allen NE, Key TJ, Appleby PN et al. Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition. Br J Cancer. 2008 May 6;98(9):1574-81.
18. Giovannucci E, Liu Y, Platz EA et al. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int.J Cancer 2007; 121 (7):1571-8
19. Gao X, LaValley MP, Tucker KL Prospective Studies of dairy product and calcium intakes and prostate cancer risk: A meta-analysis. J Natl Cancer Inst. 2005;97(23):1768-77
20. Trueman P, Hood SC, Nayak USL et al. Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK. BJU Int 1999; 83: 410-415.
21. Prostate Cancer Risk Management Programme information for primary care; PSA testing in asymptomatic men. Evidence document January 2010.